Expectations trend
FY2028 · fiscal year ending 2028-12-31 · fmp
$-0.93 → $-23.25 · observed estimates
NASDAQMaterialsIndustrial MaterialsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for OMEX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Develop strategic fertilizer production project in Mexico | The company also aims to develop fertilizer production in Mexico. | Intact | Project development stalls or is abandoned by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-12-31 · fmp
$-0.93 → $-23.25 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, early-stage critical-minerals business, not a proven earnings compounder. Its long-term thesis is in a watch state: the merger has advanced, but revenue remains limited, losses are large, and operating progress is not yet demonstrated.
The evidence snapshot provides no valuation measure or direct estimate of market expectations, so whether OMEX is cheap or expensive versus peers cannot be assessed. The business setup still depends on future merger completion, financing, and exploration progress rather than established operating results.
Near term, revenue remains low while operating losses widened from the first quarter to the second quarter of 2026. The merger registration statement became effective, but stockholder approval and other closing conditions remain; reported financing commitments do not yet show operating delivery. Recent performance is weak, and a delisting-related notice adds to the risks.
The multi-year thesis hinges first on completing the American Ocean Minerals merger and showing concrete project, customer, or permitting progress. It also depends on securing capital and converting stated commitments into execution. In the near term, Materials-sector strength could help the backdrop, while weaker sector bellwethers or a softer jobs trend could increase pressure on this cyclical business.
Over the next one to three years, OMEX remains a high-risk story with limited operating proof and substantial execution needs. The main test is whether merger, financing, and exploration plans produce measurable progress. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Debt maturity extensions support financial stability. |
| Under Pressure |
| Debt default or liquidity crisis occurs |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete merger with American Ocean Minerals | Odyssey Marine is merging with American Ocean Minerals to grow. | Improving | Merger not completed by end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “Last week, we announced a billion-dollar merger between American Ocean Minerals and Odyssey Marine Exploration.” “Merger Update The SEC’s declaration of effectiveness of the Form S-4 registration statement marks an important milestone toward completion of the proposed merger, which is intended to create a scaled, U.S.-based deep-sea critical minerals platform.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.00B → $0.00B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-23 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-24 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-25 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-26 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-27 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-28 | $-0.93 | $1,000,000 | 1 / 1 |
| 2026-10-29 | $-0.93 | $1,000,000 | 8 / 1 |
| 2026-10-30 | $-23.25 | $1,000,000 | 1 / 1 |
| 2026-10-31 | $-23.25 | $1,000,000 | 1 / 1 |
| 2026-11-01 | $-23.25 | $1,000,000 | 1 / 1 |
| 2026-11-02 | $-23.25 | $1,000,000 | 1 / 1 |
| 2026-11-03 | $-23.25 | $1,000,000 | 1 / 1 |
| 2026-11-04 | $-23.25 | $1,000,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.